Current Assets Изменить Дата
Acadia Pharmaceuticals USD 938.32M 150.03M 2024-12
Alnylam Pharmaceuticals USD 3.3B 60.14M 2024-12
Amgen USD 29.03B 2.26B 2024-12
Biogen USD 7.46B 626.3M 2024-12
BioMarin Pharmaceutical USD 3.23B 175.84M 2024-12
Cytokinetics USD 1.11B 89.34M 2024-12
Daiichi Sankyo JPY 1.98T 79.43B 2024-12
Gilead Sciences USD 19.17B 4.39B 2024-12
Incyte USD 3.24B 430.32M 2024-12
Ionis Pharmaceuticals USD 2.62B 93.56M 2024-12
Ironwood Pharmaceuticals USD 182.42M 3.81M 2024-12
Novartis USD 29.7B 1.56B 2024-12
Pfizer USD 50.36B 7.14B 2024-12
PTC Therapeutics USD 1.37B 83.98M 2024-12
Roche Holding CHF 40.04B 6.41B 2024-12
Sarepta Therapeutics USD 3.07B 388.09M 2024-12
TG Therapeutics USD 566.36M 7.71M 2024-12
Ultragenyx Pharmaceutical USD 817.12M 17.52M 2024-12
Vertex Pharmaceuticals USD 9.6B 207.7M 2024-12
Xencor USD 577.6M 4.27M 2024-12



PTC Therapeutics Текущие Активы - Текущие значения, предыдущие значения, прогнозы, графики и экономический календарь - Mar 2025.